Phesgo
(hyaluronidase / pertuzumab / trastuzumab)10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection [Phesgo]15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection [Phesgo]
Dosage & administration
biomarker testing
Phesgo clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
drug label
Phesgo prescribing information
financial assistance
Phesgo financial assistance options
Co-pay savings program
commercial only
Learn More
Foundation programs
under insured
no insurance
goverment insurance
65+
Learn More
people also ask
Phesgo FAQs
How is the dosage of Phesgo?Phesgo is available in 2 dosages, including 2,000-60-60 var units Injection 10 ml and 30,000-1,200-600 var units/15ml Injection 15 ml
What does Phesgo treat?Phesgo treats Breast Neoplasms, Extravasation of Diagnostic and Therapeutic Materials and Gastrointestinal Neoplasms
What is Phesgo made of?Phesgo contains hyaluronidase / pertuzumab / trastuzumab which is a HER2/neu Receptor Antagonist
How Is Phesgo Administered?Phesgo is administered as a Injectable
What Are The Phesgo Mechanism Of Action?Phesgo mechanism of action is HER2/Neu/cerbB2 Antagonists
FAQ Data Source